[O-18] Oral Session 18 ［Japanese］「Neuromuscular junction disorders 2」

[O-18-4] Neuromuscular complications caused by immune checkpoint inhibitors

Tomoko Noda¹, Yuji Ishihara¹, Satoki Ito¹, Haruka Ito¹, Takuya Tamura¹, Hiroki Ito¹, Akira Fukushima², Hiromichi Aso², Satoshi Sueoka³, Seiya Noda⁴, Ayuka Murakami⁵, Masahisa Katsuno⁵, Osamu Higuchi⁶, Shigeaki Suzuki⁷ (1.Department of Neurology, Ichinomiya Municipal Hospital, Japan, 2.Department of Respiratory Medicine, Ichinomiya Municipal Hospital, Japan, 3.Department of Surgery, Ichinomiya Municipal Hospital, Japan, 4.Department of Neurology, National Hospital Organization Suzuka National Hospital, Japan, 5.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 6.Department of Clinical Research, National Hospital Organization Nagasaki Kawatana Medical Center, Japan, 7.Department of Neurology, Keio University School of Medicine, Japan)